+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
siRNA/miRNA Synthesis Service Market - Global Forecast 2026-2032- Product Image
siRNA/miRNA Synthesis Service Market - Global Forecast 2026-2032- Product Image
Sale

siRNA/miRNA Synthesis Service Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6146711
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The siRNA/miRNA Synthesis Service Market is projected to reach USD 128.28 Billion in 2026. It is expected to continue growing at a CAGR of 4.29%, reaching USD 165.43 Billion by 2032.

siRNA and miRNA Synthesis Services: Executive Overview

siRNA and miRNA synthesis services support research and development involving RNA interference, gene regulation, functional genomics, biomarker discovery, and therapeutic development. Providers typically assist with sequence design, chemical modification, purification, quality control, and delivery of research-grade or development-grade oligonucleotides. Demand is shaped by expanding RNA biology research, the need for reproducible custom materials, and greater emphasis on sequence integrity and documentation.

RNA Biology Is Shifting Toward More Specialized, Quality-Centric Workflows

The landscape is moving from basic oligonucleotide production toward integrated workflows that connect design, synthesis, modification, purification, analytical characterization, and application support. Researchers increasingly require chemically stabilized sequences, reduced off-target activity, compatibility with demanding delivery systems, and lot-to-lot consistency. Regulatory expectations and translational research requirements are also encouraging stronger traceability, validated analytical methods, and clearer documentation across the development process.

Artificial Intelligence Is Accelerating Design, Screening, and Quality Operations

Artificial intelligence is contributing to siRNA and miRNA workflows by helping prioritize target sequences, identify potential off-target interactions, analyze secondary-structure characteristics, and support experimental design. Machine-learning methods can also assist with literature interpretation, assay optimization, and quality-control anomaly detection. Their value remains dependent on high-quality training data, experimental validation, transparent decision criteria, and careful management of sequence privacy and intellectual property.

Regional Differences Reflect Research Intensity, Infrastructure, and Regulatory Maturity

North America combines strong biotechnology activity, advanced translational research infrastructure, and substantial demand for customized RNA materials. Europe emphasizes quality systems, collaborative research networks, and regulatory alignment across the European Union. Asia-Pacific benefits from expanding life-science capabilities, growing academic and biopharmaceutical research, and increasingly sophisticated manufacturing infrastructure. Latin America is developing through university, diagnostics, and biotechnology initiatives, while adoption can be constrained by procurement complexity and specialized supply requirements. The Middle East is strengthening research capacity through institutional investment and healthcare innovation programs. Africa presents emerging opportunities linked to genomics, infectious-disease research, and laboratory-capacity development, alongside infrastructure and access challenges.

Economic and Security Groups Shape Collaboration and Supply Resilience

ASEAN economies are strengthening biotechnology links and regional research capacity, creating demand for dependable cross-border supply and technical support. BRICS members span major research and manufacturing environments, but differ in regulatory systems, infrastructure, and access to specialized reagents. The European Union benefits from harmonized scientific and regulatory frameworks while retaining national procurement considerations. G7 countries generally combine mature research ecosystems with strong expectations for quality, data integrity, and intellectual-property protection. GCC states are investing in healthcare and life-science capabilities, whereas NATO members place additional emphasis on resilient supply chains, trusted procurement, and continuity of critical research inputs.

Country-Level Priorities Range from Translational Research to Manufacturing Capability

The United States and Canada emphasize advanced biomedical research, translational development, and stringent documentation. Germany, France, Italy, Spain, and the United Kingdom combine established academic and biopharmaceutical ecosystems with strong quality and compliance expectations. China, Japan, South Korea, India, and Australia are expanding capabilities in genomics, RNA research, and biotechnology manufacturing, with varied regulatory and procurement environments. Brazil and Mexico are developing research and diagnostic capacity while addressing access, logistics, and local infrastructure considerations. Russia maintains scientific expertise in selected areas but faces additional constraints related to international collaboration and supply continuity.

Industry Leaders Should Build Quality, Flexibility, and Resilience into Service Models

Leaders should offer modular workflows spanning design, synthesis, modification, purification, and analytical testing, while clearly separating research-use and regulated-development requirements. Investment in sequence-design software, human scientific review, and experimentally verified quality controls can improve reliability without treating algorithmic output as a substitute for validation. Regionalized inventory, qualified backup suppliers, transparent chain-of-custody records, and consistent documentation can reduce disruption risks. Customer-facing portals should provide clear specifications, status visibility, certificates, and technical guidance tailored to academic, biotechnology, pharmaceutical, and diagnostic users.

Methodology: Evidence-Led Synthesis of Market Structure and Adoption Drivers

This executive summary uses the defined siRNA/miRNA synthesis service scope and organizes qualitative findings around service capabilities, research applications, workflow requirements, technology shifts, geographic conditions, and institutional groupings. Regional, group, and country observations are presented as contextual analysis rather than quantified market claims. No market estimates, shares, forecasts, or company-specific assertions are included. Conclusions should be validated against current primary interviews, regulatory documents, procurement records, peer-reviewed literature, and supplier capability assessments before strategic decisions are made.

Strategic Outlook: Reliable RNA Workflows Will Differentiate Service Providers

siRNA and miRNA synthesis services are becoming increasingly important to RNA biology, functional genomics, and translational research. Competitive differentiation will depend less on synthesis alone and more on integrated design support, chemical expertise, analytical rigor, data transparency, and dependable delivery. Providers that combine adaptable service platforms with responsible artificial-intelligence use, regional resilience, and application-focused scientific support will be better positioned to meet evolving research and development requirements.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. siRNA/miRNA Synthesis Service Market, by Service Type
7.1. Introduction
7.2. Catalog Synthesis
7.3. Custom Synthesis
7.3.1. Library Synthesis
7.3.2. Single Product
8. siRNA/miRNA Synthesis Service Market, by Product Type
8.1. Introduction
8.2. Mirna
8.2.1. Mature Mirna
8.2.2. Precursor Mirna
8.3. Sirna
8.3.1. Chemically Modified
8.3.2. Unmodified
9. siRNA/miRNA Synthesis Service Market, by Therapeutic Area
9.1. Introduction
9.2. Cardiovascular
9.3. Neurology
9.4. Oncology
10. siRNA/miRNA Synthesis Service Market, by Scale
10.1. Introduction
10.2. Industrial Scale
10.3. Laboratory Scale
10.3.1. Bench Scale
10.3.2. Pilot Scale
11. siRNA/miRNA Synthesis Service Market, by Modification Type
11.1. Introduction
11.2. Chemically Modified
11.2.1. 2'-O-Methyl
11.2.2. Locked Nucleic Acid
11.3. Unmodified
12. siRNA/miRNA Synthesis Service Market, by Delivery Mode
12.1. Introduction
12.2. Conjugates
12.3. Lipid Nanoparticles
12.4. Polymer Complexes
13. siRNA/miRNA Synthesis Service Market, by Application
13.1. Introduction
13.2. In Silico
13.3. In Vitro
13.4. In Vivo
14. siRNA/miRNA Synthesis Service Market, by End User
14.1. Introduction
14.2. Academic Research Institutes
14.3. Contract Research Organizations
14.4. Hospitals
14.5. Pharmaceutical Biotech Companies
15. siRNA/miRNA Synthesis Service Market, by Region
15.1. Introduction
15.2. Asia-Pacific
15.3. North America
15.4. Latin America
15.5. Europe
15.6. Middle East
15.7. Africa
16. siRNA/miRNA Synthesis Service Market, by Group
16.1. Introduction
16.2. ASEAN
16.3. GCC
16.4. European Union
16.5. BRICS
16.6. G7
16.7. NATO
17. siRNA/miRNA Synthesis Service Market, by Country
17.1. Introduction
17.2. United States
17.3. Canada
17.4. Mexico
17.5. Brazil
17.6. United Kingdom
17.7. Germany
17.8. France
17.9. Russia
17.10. Italy
17.11. Spain
17.12. China
17.13. India
17.14. Japan
17.15. Australia
17.16. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. Market Concentration Analysis, 2025
18.2.1. Concentration Ratio (CR)
18.2.2. Herfindahl Hirschman Index (HHI)
18.3. Recent Developments & Impact Analysis, 2025
18.4. Product Portfolio Analysis, 2025
18.5. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Aldevron, Inc.
19.2. Bioneer Corporation
19.3. BOC Sciences, Inc.
19.4. Creative Biogene, Inc.
19.5. Creative Biolabs, Inc.
19.6. Eurofins Genomics GmbH
19.7. GenScript Biotech Corporation
19.8. Horizon Discovery Group plc
19.9. Integrated DNA Technologies, Inc.
19.10. Lonza Group AG
19.11. Merck KGaA
19.12. Sangon Biotech Co., Ltd.
19.13. Synbio Technologies, Inc.
19.14. Thermo Fisher Scientific Inc.
19.15. TriLink BioTechnologies, Inc.
20. Key Experts
LIST OF FIGURES
FIGURE 1. Global siRNA/miRNA Synthesis Service Market, Years Considered for the Study
FIGURE 2. Global siRNA/miRNA Synthesis Service Market, Research Design
FIGURE 3. Global siRNA/miRNA Synthesis Service Market, Research Framework
FIGURE 4. Global siRNA/miRNA Synthesis Service Market, Data Triangulation
FIGURE 5. Global siRNA/miRNA Synthesis Service Market Size, 2017-2032 (USD Million)
FIGURE 6. Global siRNA/miRNA Synthesis Service Market Size, by Service Type, 2025 vs 2032 (%)
FIGURE 7. Global siRNA/miRNA Synthesis Service Market Size, by Service Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global siRNA/miRNA Synthesis Service Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global siRNA/miRNA Synthesis Service Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2025 vs 2032 (%)
FIGURE 11. Global siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global siRNA/miRNA Synthesis Service Market Size, by Scale, 2025 vs 2032 (%)
FIGURE 13. Global siRNA/miRNA Synthesis Service Market Size, by Scale, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2025 vs 2032 (%)
FIGURE 15. Global siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2025 vs 2032 (%)
FIGURE 17. Global siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global siRNA/miRNA Synthesis Service Market Size, by Application, 2025 vs 2032 (%)
FIGURE 19. Global siRNA/miRNA Synthesis Service Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global siRNA/miRNA Synthesis Service Market Size, by End User, 2025 vs 2032 (%)
FIGURE 21. Global siRNA/miRNA Synthesis Service Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global siRNA/miRNA Synthesis Service Market Size, by Region, 2025 vs 2032 (%)
FIGURE 23. Global siRNA/miRNA Synthesis Service Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global siRNA/miRNA Synthesis Service Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global siRNA/miRNA Synthesis Service Market Size, by Country, 2025 vs 2032 (%)
FIGURE 26. Global siRNA/miRNA Synthesis Service Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global siRNA/miRNA Synthesis Service Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global siRNA/miRNA Synthesis Service Market Segmentation & Coverage
TABLE 2. Global siRNA/miRNA Synthesis Service Market Size, 2017-2032 (USD Million)
TABLE 3. Global siRNA/miRNA Synthesis Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 4. Global Catalog Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Catalog Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Catalog Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Custom Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Custom Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Custom Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Library Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Library Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Library Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Single Product Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Single Product Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Single Product Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global siRNA/miRNA Synthesis Service Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 17. Global Mirna Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Mirna Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Mirna Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Mature Mirna Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Mature Mirna Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Mature Mirna Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Precursor Mirna Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Precursor Mirna Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Precursor Mirna Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Sirna Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Sirna Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Sirna Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Chemically Modified Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Chemically Modified Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Chemically Modified Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Unmodified Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Unmodified Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Unmodified Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 36. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global siRNA/miRNA Synthesis Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 46. Global Industrial Scale Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Industrial Scale Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Industrial Scale Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Laboratory Scale Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Laboratory Scale Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Laboratory Scale Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Bench Scale Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Bench Scale Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Bench Scale Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Pilot Scale Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Pilot Scale Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Pilot Scale Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2017-2032 (USD Million)
TABLE 59. Global Chemically Modified Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Chemically Modified Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Chemically Modified Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global 2'-O-Methyl Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global 2'-O-Methyl Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global 2'-O-Methyl Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Locked Nucleic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Locked Nucleic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Locked Nucleic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Unmodified Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Unmodified Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Unmodified Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 72. Global Conjugates Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Conjugates Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Conjugates Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Lipid Nanoparticles Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Lipid Nanoparticles Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Lipid Nanoparticles Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Polymer Complexes Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Polymer Complexes Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Polymer Complexes Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global siRNA/miRNA Synthesis Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 82. Global In Silico Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global In Silico Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global In Silico Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global In Vitro Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global In Vitro Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global In Vitro Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global In Vivo Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global In Vivo Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global In Vivo Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global siRNA/miRNA Synthesis Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Global Academic Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Academic Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Academic Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Pharmaceutical Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Pharmaceutical Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Pharmaceutical Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global siRNA/miRNA Synthesis Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific siRNA/miRNA Synthesis Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific siRNA/miRNA Synthesis Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific siRNA/miRNA Synthesis Service Market Size, by Custom Synthesis, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific siRNA/miRNA Synthesis Service Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific siRNA/miRNA Synthesis Service Market Size, by Mirna, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific siRNA/miRNA Synthesis Service Market Size, by Sirna, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific siRNA/miRNA Synthesis Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific siRNA/miRNA Synthesis Service Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific siRNA/miRNA Synthesis Service Market Size, by Chemically Modified, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific siRNA/miRNA Synthesis Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific siRNA/miRNA Synthesis Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 119. North America siRNA/miRNA Synthesis Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. North America siRNA/miRNA Synthesis Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 121. North America siRNA/miRNA Synthesis Service Market Size, by Custom Synthesis, 2017-2032 (USD Million)
TABLE 122. North America siRNA/miRNA Synthesis Service Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 123. North America siRNA/miRNA Synthesis Service Market Size, by Mirna, 2017-2032 (USD Million)
TABLE 124. North America siRNA/miRNA Synthesis Service Market Size, by Sirna, 2017-2032 (USD Million)
TABLE 125. North America siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 126. North America siRNA/miRNA Synthesis Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 127. North America siRNA/miRNA Synthesis Service Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 128. North America siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2017-2032 (USD Million)
TABLE 129. North America siRNA/miRNA Synthesis Service Market Size, by Chemically Modified, 2017-2032 (USD Million)
TABLE 130. North America siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 131. North America siRNA/miRNA Synthesis Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. North America siRNA/miRNA Synthesis Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. Latin America siRNA/miRNA Synthesis Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Latin America siRNA/miRNA Synthesis Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 135. Latin America siRNA/miRNA Synthesis Service Market Size, by Custom Synthesis, 2017-2032 (USD Million)
TABLE 136. Latin America siRNA/miRNA Synthesis Service Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 137. Latin America siRNA/miRNA Synthesis Service Market Size, by Mirna, 2017-2032 (USD Million)
TABLE 138. Latin America siRNA/miRNA Synthesis Service Market Size, by Sirna, 2017-2032 (USD Million)
TABLE 139. Latin America siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 140. Latin America siRNA/miRNA Synthesis Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 141. Latin America siRNA/miRNA Synthesis Service Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 142. Latin America siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2017-2032 (USD Million)
TABLE 143. Latin America siRNA/miRNA Synthesis Service Market Size, by Chemically Modified, 2017-2032 (USD Million)
TABLE 144. Latin America siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 145. Latin America siRNA/miRNA Synthesis Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. Latin America siRNA/miRNA Synthesis Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. Europe siRNA/miRNA Synthesis Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Europe siRNA/miRNA Synthesis Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 149. Europe siRNA/miRNA Synthesis Service Market Size, by Custom Synthesis, 2017-2032 (USD Million)
TABLE 150. Europe siRNA/miRNA Synthesis Service Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. Europe siRNA/miRNA Synthesis Service Market Size, by Mirna, 2017-2032 (USD Million)
TABLE 152. Europe siRNA/miRNA Synthesis Service Market Size, by Sirna, 2017-2032 (USD Million)
TABLE 153. Europe siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 154. Europe siRNA/miRNA Synthesis Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 155. Europe siRNA/miRNA Synthesis Service Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 156. Europe siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2017-2032 (USD Million)
TABLE 157. Europe siRNA/miRNA Synthesis Service Market Size, by Chemically Modified, 2017-2032 (USD Million)
TABLE 158. Europe siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 159. Europe siRNA/miRNA Synthesis Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. Europe siRNA/miRNA Synthesis Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. Middle East siRNA/miRNA Synthesis Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Middle East siRNA/miRNA Synthesis Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 163. Middle East siRNA/miRNA Synthesis Service Market Size, by Custom Synthesis, 2017-2032 (USD Million)
TABLE 164. Middle East siRNA/miRNA Synthesis Service Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 165. Middle East siRNA/miRNA Synthesis Service Market Size, by Mirna, 2017-2032 (USD Million)
TABLE 166. Middle East siRNA/miRNA Synthesis Service Market Size, by Sirna, 2017-2032 (USD Million)
TABLE 167. Middle East siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 168. Middle East siRNA/miRNA Synthesis Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 169. Middle East siRNA/miRNA Synthesis Service Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 170. Middle East siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2017-2032 (USD Million)
TABLE 171. Middle East siRNA/miRNA Synthesis Service Market Size, by Chemically Modified, 2017-2032 (USD Million)
TABLE 172. Middle East siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 173. Middle East siRNA/miRNA Synthesis Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Middle East siRNA/miRNA Synthesis Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Africa siRNA/miRNA Synthesis Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. Africa siRNA/miRNA Synthesis Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 177. Africa siRNA/miRNA Synthesis Service Market Size, by Custom Synthesis, 2017-2032 (USD Million)
TABLE 178. Africa siRNA/miRNA Synthesis Service Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 179. Africa siRNA/miRNA Synthesis Service Market Size, by Mirna, 2017-2032 (USD Million)
TABLE 180. Africa siRNA/miRNA Synthesis Service Market Size, by Sirna, 2017-2032 (USD Million)
TABLE 181. Africa siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 182. Africa siRNA/miRNA Synthesis Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 183. Africa siRNA/miRNA Synthesis Service Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 184. Africa siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2017-2032 (USD Million)
TABLE 185. Africa siRNA/miRNA Synthesis Service Market Size, by Chemically Modified, 2017-2032 (USD Million)
TABLE 186. Africa siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 187. Africa siRNA/miRNA Synthesis Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 188. Africa siRNA/miRNA Synthesis Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. Global siRNA/miRNA Synthesis Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 190. ASEAN siRNA/miRNA Synthesis Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. ASEAN siRNA/miRNA Synthesis Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 192. ASEAN siRNA/miRNA Synthesis Service Market Size, by Custom Synthesis, 2017-2032 (USD Million)
TABLE 193. ASEAN siRNA/miRNA Synthesis Service Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 194. ASEAN siRNA/miRNA Synthesis Service Market Size, by Mirna, 2017-2032 (USD Million)
TABLE 195. ASEAN siRNA/miRNA Synthesis Service Market Size, by Sirna, 2017-2032 (USD Million)
TABLE 196. ASEAN siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 197. ASEAN siRNA/miRNA Synthesis Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 198. ASEAN siRNA/miRNA Synthesis Service Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 199. ASEAN siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2017-2032 (USD Million)
TABLE 200. ASEAN siRNA/miRNA Synthesis Service Market Size, by Chemically Modified, 2017-2032 (USD Million)
TABLE 201. ASEAN siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 202. ASEAN siRNA/miRNA Synthesis Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. ASEAN siRNA/miRNA Synthesis Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. GCC siRNA/miRNA Synthesis Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 205. GCC siRNA/miRNA Synthesis Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 206. GCC siRNA/miRNA Synthesis Service Market Size, by Custom Synthesis, 2017-2032 (USD Million)
TABLE 207. GCC siRNA/miRNA Synthesis Service Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 208. GCC siRNA/miRNA Synthesis Service Market Size, by Mirna, 2017-2032 (USD Million)
TABLE 209. GCC siRNA/miRNA Synthesis Service Market Size, by Sirna, 2017-2032 (USD Million)
TABLE 210. GCC siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 211. GCC siRNA/miRNA Synthesis Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 212. GCC siRNA/miRNA Synthesis Service Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 213. GCC siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2017-2032 (USD Million)
TABLE 214. GCC siRNA/miRNA Synthesis Service Market Size, by Chemically Modified, 2017-2032 (USD Million)
TABLE 215. GCC siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 216. GCC siRNA/miRNA Synthesis Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. GCC siRNA/miRNA Synthesis Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. European Union siRNA/miRNA Synthesis Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 219. European Union siRNA/miRNA Synthesis Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 220. European Union siRNA/miRNA Synthesis Service Market Size, by Custom Synthesis, 2017-2032 (USD Million)
TABLE 221. European Union siRNA/miRNA Synthesis Service Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 222. European Union siRNA/miRNA Synthesis Service Market Size, by Mirna, 2017-2032 (USD Million)
TABLE 223. European Union siRNA/miRNA Synthesis Service Market Size, by Sirna, 2017-2032 (USD Million)
TABLE 224. European Union siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 225. European Union siRNA/miRNA Synthesis Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 226. European Union siRNA/miRNA Synthesis Service Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 227. European Union siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2017-2032 (USD Million)
TABLE 228. European Union siRNA/miRNA Synthesis Service Market Size, by Chemically Modified, 2017-2032 (USD Million)
TABLE 229. European Union siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 230. European Union siRNA/miRNA Synthesis Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 231. European Union siRNA/miRNA Synthesis Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. BRICS siRNA/miRNA Synthesis Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 233. BRICS siRNA/miRNA Synthesis Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 234. BRICS siRNA/miRNA Synthesis Service Market Size, by Custom Synthesis, 2017-2032 (USD Million)
TABLE 235. BRICS siRNA/miRNA Synthesis Service Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 236. BRICS siRNA/miRNA Synthesis Service Market Size, by Mirna, 2017-2032 (USD Million)
TABLE 237. BRICS siRNA/miRNA Synthesis Service Market Size, by Sirna, 2017-2032 (USD Million)
TABLE 238. BRICS siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 239. BRICS siRNA/miRNA Synthesis Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 240. BRICS siRNA/miRNA Synthesis Service Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 241. BRICS siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2017-2032 (USD Million)
TABLE 242. BRICS siRNA/miRNA Synthesis Service Market Size, by Chemically Modified, 2017-2032 (USD Million)
TABLE 243. BRICS siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 244. BRICS siRNA/miRNA Synthesis Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. BRICS siRNA/miRNA Synthesis Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. G7 siRNA/miRNA Synthesis Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 247. G7 siRNA/miRNA Synthesis Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 248. G7 siRNA/miRNA Synthesis Service Market Size, by Custom Synthesis, 2017-2032 (USD Million)
TABLE 249. G7 siRNA/miRNA Synthesis Service Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 250. G7 siRNA/miRNA Synthesis Service Market Size, by Mirna, 2017-2032 (USD Million)
TABLE 251. G7 siRNA/miRNA Synthesis Service Market Size, by Sirna, 2017-2032 (USD Million)
TABLE 252. G7 siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 253. G7 siRNA/miRNA Synthesis Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 254. G7 siRNA/miRNA Synthesis Service Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 255. G7 siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2017-2032 (USD Million)
TABLE 256. G7 siRNA/miRNA Synthesis Service Market Size, by Chemically Modified, 2017-2032 (USD Million)
TABLE 257. G7 siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 258. G7 siRNA/miRNA Synthesis Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. G7 siRNA/miRNA Synthesis Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. NATO siRNA/miRNA Synthesis Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 261. NATO siRNA/miRNA Synthesis Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 262. NATO siRNA/miRNA Synthesis Service Market Size, by Custom Synthesis, 2017-2032 (USD Million)
TABLE 263. NATO siRNA/miRNA Synthesis Service Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 264. NATO siRNA/miRNA Synthesis Service Market Size, by Mirna, 2017-2032 (USD Million)
TABLE 265. NATO siRNA/miRNA Synthesis Service Market Size, by Sirna, 2017-2032 (USD Million)
TABLE 266. NATO siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 267. NATO siRNA/miRNA Synthesis Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 268. NATO siRNA/miRNA Synthesis Service Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 269. NATO siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2017-2032 (USD Million)
TABLE 270. NATO siRNA/miRNA Synthesis Service Market Size, by Chemically Modified, 2017-2032 (USD Million)
TABLE 271. NATO siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 272. NATO siRNA/miRNA Synthesis Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 273. NATO siRNA/miRNA Synthesis Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. Global siRNA/miRNA Synthesis Service Market Size, by Country, 2017-2032 (USD Million)
TABLE 275. United States siRNA/miRNA Synthesis Service Market Size, 2017-2032 (USD Million)
TABLE 276. United States siRNA/miRNA Synthesis Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 277. United States siRNA/miRNA Synthesis Service Market Size, by Custom Synthesis, 2017-2032 (USD Million)
TABLE 278. United States siRNA/miRNA Synthesis Service Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 279. United States siRNA/miRNA Synthesis Service Market Size, by Mirna, 2017-2032 (USD Million)
TABLE 280. United States siRNA/miRNA Synthesis Service Market Size, by Sirna, 2017-2032 (USD Million)
TABLE 281. United States siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 282. United States siRNA/miRNA Synthesis Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 283. United States siRNA/miRNA Synthesis Service Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 284. United States siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2017-2032 (USD Million)
TABLE 285. United States siRNA/miRNA Synthesis Service Market Size, by Chemically Modified, 2017-2032 (USD Million)
TABLE 286. United States siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 287. United States siRNA/miRNA Synthesis Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 288. United States siRNA/miRNA Synthesis Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 289. Canada siRNA/miRNA Synthesis Service Market Size, 2017-2032 (USD Million)
TABLE 290. Canada siRNA/miRNA Synthesis Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 291. Canada siRNA/miRNA Synthesis Service Market Size, by Custom Synthesis, 2017-2032 (USD Million)
TABLE 292. Canada siRNA/miRNA Synthesis Service Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 293. Canada siRNA/miRNA Synthesis Service Market Size, by Mirna, 2017-2032 (USD Million)
TABLE 294. Canada siRNA/miRNA Synthesis Service Market Size, by Sirna, 2017-2032 (USD Million)
TABLE 295. Canada siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 296. Canada siRNA/miRNA Synthesis Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 297. Canada siRNA/miRNA Synthesis Service Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 298. Canada siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2017-2032 (USD Million)
TABLE 299. Canada siRNA/miRNA Synthesis Service Market Size, by Chemically Modified, 2017-2032 (USD Million)
TABLE 300. Canada siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 301. Canada siRNA/miRNA Synthesis Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 302. Canada siRNA/miRNA Synthesis Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. Mexico siRNA/miRNA Synthesis Service Market Size, 2017-2032 (USD Million)
TABLE 304. Mexico siRNA/miRNA Synthesis Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 305. Mexico siRNA/miRNA Synthesis Service Market Size, by Custom Synthesis, 2017-2032 (USD Million)
TABLE 306. Mexico siRNA/miRNA Synthesis Service Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 307. Mexico siRNA/miRNA Synthesis Service Market Size, by Mirna, 2017-2032 (USD Million)
TABLE 308. Mexico siRNA/miRNA Synthesis Service Market Size, by Sirna, 2017-2032 (USD Million)
TABLE 309. Mexico siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 310. Mexico siRNA/miRNA Synthesis Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 311. Mexico siRNA/miRNA Synthesis Service Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 312. Mexico siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2017-2032 (USD Million)
TABLE 313. Mexico siRNA/miRNA Synthesis Service Market Size, by Chemically Modified, 2017-2032 (USD Million)
TABLE 314. Mexico siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 315. Mexico siRNA/miRNA Synthesis Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 316. Mexico siRNA/miRNA Synthesis Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 317. Brazil siRNA/miRNA Synthesis Service Market Size, 2017-2032 (USD Million)
TABLE 318. Brazil siRNA/miRNA Synthesis Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 319. Brazil siRNA/miRNA Synthesis Service Market Size, by Custom Synthesis, 2017-2032 (USD Million)
TABLE 320. Brazil siRNA/miRNA Synthesis Service Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 321. Brazil siRNA/miRNA Synthesis Service Market Size, by Mirna, 2017-2032 (USD Million)
TABLE 322. Brazil siRNA/miRNA Synthesis Service Market Size, by Sirna, 2017-2032 (USD Million)
TABLE 323. Brazil siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 324. Brazil siRNA/miRNA Synthesis Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 325. Brazil siRNA/miRNA Synthesis Service Market Size, by Laboratory Scale, 2017-2032 (USD Million)
TABLE 326. Brazil siRNA/miRNA Synthesis Service Market Size, by Modification Type, 2017-2032 (USD Million)
TABLE 327. Brazil siRNA/miRNA Synthesis Service Market Size, by Chemically Modified, 2017-2032 (USD Million)
TABLE 328. Brazil siRNA/miRNA Synthesis Service Market Size, by Delivery Mode, 2017-2032 (USD Million)
TABLE 329. Brazil siRNA/miRNA Synthesis Service Market Size, by Application, 2017-2032 (USD Million)
TABLE 330. Brazil siRNA/miRNA Synthesis Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 331. United Kingdom siRNA/miRNA Synthesis Service Market Size, 2017-2032 (USD Million)
TABLE 332. United Kingdom siRNA/miRNA Synthesis Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 333. United Kingdom siRNA/miRNA Synthesis Service Market Size, by Custom Synthesis, 2017-2032 (USD Million)
TABLE 334. United Kingdom siRNA/miRNA Synthesis Service Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 335. United Kingdom siRNA/miRNA Synthesis Service Market Size, by Mirna, 2017-2032 (USD Million)
TABLE 336. United Kingdom siRNA/miRNA Synthesis Service Market Size, by Sirna, 2017-2032 (USD Million)
TABLE 337. United Kingdom siRNA/miRNA Synthesis Service Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 338. United Kingdom siRNA/miRNA Synthesis Service Market Size, by Scale, 2017-2032 (USD Million)
TABLE 339. United Kingdom siRNA/miRNA Synthesis Service Market Size, by Laboratory Scale, 2017-2032 (U

Companies Mentioned

  • Aldevron, Inc.
  • Bioneer Corporation
  • BOC Sciences, Inc.
  • Creative Biogene, Inc.
  • Creative Biolabs, Inc.
  • Eurofins Genomics GmbH
  • GenScript Biotech Corporation
  • Horizon Discovery Group plc
  • Integrated DNA Technologies, Inc.
  • Lonza Group AG
  • Merck KGaA
  • Sangon Biotech Co., Ltd.
  • Synbio Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • TriLink BioTechnologies, Inc.

Related Topics

Related Reports

RNA Therapeutics Market Outlook 2026-2034: Market Share, and Growth Analysis by Therapeutic Modality (Antisense Oligonucleotides, Small Interfering RNA (siRNA), MicroRNA (miRNA) Therapeutics, Messenger RNA (mRNA) Therapeutics, RNA Aptamers), Application, End User - Product Image

RNA Therapeutics Market Outlook 2026-2034: Market Share, and Growth Analysis by Therapeutic Modality (Antisense Oligonucleotides, Small Interfering RNA (siRNA), MicroRNA (miRNA) Therapeutics, Messenger RNA (mRNA) Therapeutics, RNA Aptamers), Application, End User

  • Report
  • 160 Pages
  • Global
From
miRNA Sequencing and Assays - Global Strategic Business Report - Product Image

miRNA Sequencing and Assays - Global Strategic Business Report

  • Report
  • 465 Pages
  • Global
From
MiRNA Sequencing and Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

MiRNA Sequencing and Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
miRNA Sequencing & Assay Market - Global Forecast 2026-2032 - Product Image

miRNA Sequencing & Assay Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Microrna (MIRNA) Market 2026-2030 - Product Image

Microrna (MIRNA) Market 2026-2030

  • Report
  • 291 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.